Cardiovascular risk profile and events before and after treatment with anti-VEGF drugs in the setting of a structured cardio-oncologic program

Eur J Prev Cardiol. 2021 Aug 9;28(9):e38-e40. doi: 10.1177/2047487320923056.

Giacomo Tini^{1

2}, Matteo Sarocchi¹, Davide Sirello^{1

2}, Roberto Murialdo³, Giuseppe Fornarini⁴, Giulia Buzzatti⁵, Francesco Boccardo^{2

6}, Eleonora Arboscello⁷, Italo Porto^{1

2}, Pietro Ameri^{1

2}, Paolo Spallarossa¹

¹ Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, IRCCS Italian Cardiovascular Network, Italy.
² Department of Internal Medicine, University of Genova, Italy.
³ Internal Medicine Unit, IRCCS Ospedale Policlinico San Martino, Italy.
⁴ Medical Oncology Unit, IRCCS Ospedale Policlinico San Martino, Italy.
⁵ Breast Unit, IRCCS Ospedale Policlinico San Martino, Italy.
⁶ Academic Unit of Medical Oncology, IRCCS Ospedale Policlinico San Martino, Italy.
⁷ Department of Emergency, IRCCS Ospedale Policlinico San Martino, Italy.

No abstract available

Publication types